Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Erythrocytapheresis Versus Phlebotomy as Maintenance Therapy in Patients With Hereditary Hemochromatosis; a Randomised, Single Blinded Sequential, Cross-over Trial

NCT01398644 is registered in ClinicalTrials.gov with Sanquin Research & Blood Bank Divisions as lead sponsor.

NCT NCT01398644
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01398644 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Erythrocytapheresis Versus Phlebotomy as Maintenance Therapy in Patients With Hereditary Hemochromatosis; a Randomised, Single Blinded Sequential, Cross-over Trial
Lead sponsor
Sanquin Research & Blood Bank Divisions
Phase
Phase 3
Overall status
Unknown status
Start date
May 31, 2008
Completion date
December 31, 2013
Enrollment
40 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hereditary hemochromatosis